Open AccessAn Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future Research on Doxazosin
Author(s) -
Anne Richards,
Sabra S. Inslicht,
Leslie Ruoff,
Thomas J. Metzler,
Lizabeth A. Goldstein,
Christen Mary Chapman,
Samantha Q. Hubachek,
Thomas C. Neylan
Publication year - 2018
Publication title -
focus/focus (american psychiatric publishing. online)
Language(s) - English
Resource type - Journals
eISSN - 1541-4108
pISSN - 1541-4094
DOI - 10.1176/appi.focus.20170031
Subject(s) - doxazosin , posttraumatic stress , psychology , clinical psychology , medicine , psychiatry , blood pressure
This report presents findings from an eight-week, open-label study of doxazosin extended-release for nightmares, sleep disturbance, and overall clinical symptoms in posttraumatic stress disorder (PTSD). Recommendations for future studies of doxazosin are provided.